Dow Up 0.13% Nasdaq Up 0.57%

Oncothyreon Inc (ONTY)

-NasdaqGS
1.74 Up 0.05(2.66%) 10:39AM EST - Nasdaq Real Time Price
Prev Close:1.69
Open:1.70
Bid:1.74 x 2400
Ask:1.75 x 10800
1y Target Est:3.67
Beta:1.51
Next Earnings Date:N/A
Day's Range:1.70 - 1.75
52wk Range:1.52 - 4.08
Volume:66,946
Avg Vol (3m):613,258
Market Cap:158.85M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ONTY

Comparison

Symbol% ChgMkt Cap
ONTYUp 2.66%158.85M
GSKDown 0.16%111.37B
RHHBY 0.00%253.65B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-14) :-0.40
Quarterly EPS Est (Dec-14) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback